Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group-Reference-Cited by-同舟云学术

Clinical course of lung physiology in patients with scleroderma and interstitial lung disease: Analysis of the Scleroderma Lung Study Placebo Group

Published:2011-09-27 Issue:10 Volume:63 Page:3078-3085
ISSN:0004-3591
Container-title:Arthritis & Rheumatism
language:en
Short-container-title:Arthritis & Rheumatism

Author:

Khanna Dinesh,Tseng Chi-Hong,Farmani Niloofar,Steen Virginia,Furst Daniel E.,Clements Philip J.,Roth Michael D.,Goldin Jonathan,Elashoff Robert,Seibold James R.,Saggar Rajeev,Tashkin Donald P.

Funder

NIH (National Institute of Arthritis and Musculoskeletal and Skin Diseases award)

Scleroderma Foundation (New Investigator Award)

NIH/PHS (National Heart, Lung, and Blood Institute)

Publisher

Wiley

Subject

Pharmacology (medical),Immunology,Rheumatology,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/art.30467/fullpdf

Reference19 articles.

1. Changes in causes of death in systemic sclerosis, 1972-2002;Steen;Ann Rheum Dis,2007

2. Severe restrictive lung disease in systemic sclerosis;Steen;Arthritis Rheum,1994

3. Scleroderma lung: initial forced vital capacity as predictor of pulmonary function decline;Plastiras;Arthritis Rheum,2006

4. Interstitial lung disease in systemic sclerosis: a simple staging system;Goh;Am J Respir Crit Care Med,2008

5. Cyclophosphamide versus placebo in scleroderma lung disease;Tashkin;N Engl J Med,2006

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinically Relevant Biomarkers in Connective Tissue Disease-Associated Interstitial Lung Disease;Rheumatic Disease Clinics of North America;2024-08

2. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis & Rheumatology;2024-07-08

3. 2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases;Arthritis Care & Research;2024-07-08

4. Interstitial Lung Disease Associated with Systemic Sclerosis;Seminars in Respiratory and Critical Care Medicine;2024-05-07

5. Comparison of nintedanib-induced gastrointestinal adverse events between patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias;Respiratory Investigation;2024-05